JOSÉ LUIS
MARCO CONTELLES
Investigador en el periodo 2018-2019
Publicaciones (403) Publicaciones en las que ha participado algún/a investigador/a
2024
-
Synthesis and Biological Evaluation of New Benzochromenopyrimidines for the Therapy of Colon and Lung Cancer
ChemistrySelect, Vol. 9, Núm. 2
-
Synthesis, antioxidant and neuroprotective analysis of diversely functionalized α-aryl-N-alkyl nitrones as potential agents for ischemic stroke therapy
European Journal of Medicinal Chemistry, Vol. 266
2023
-
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
Acta Pharmaceutica Sinica B, Vol. 13, Núm. 5, pp. 2152-2175
-
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
Molecules, Vol. 28, Núm. 1
-
Design, Synthesis, in Silico and Biological Evaluation of Novel 4-Aminopyrimidine-5-carbonitriles
ChemistrySelect, Vol. 8, Núm. 31
-
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
International Journal of Molecular Sciences, Vol. 24, Núm. 11
-
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
Antioxidants, Vol. 12, Núm. 7
-
Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models
Scientific Reports, Vol. 13, Núm. 1
-
Synthesis and Antioxidant Properties of Novel 1,2,3-Triazole-Containing Nitrones
Antioxidants, Vol. 12, Núm. 1
-
The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy
International Journal of Molecular Sciences, Vol. 24, Núm. 15
2022
-
Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
Molecules, Vol. 27, Núm. 22
-
Improving the Efficacy of Quinolylnitrones for Ischemic Stroke Therapy, QN4 and QN15 as New Neuroprotective Agents after Oxygen–Glucose Deprivation/Reoxygenation-Induced Neuronal Injury
Pharmaceuticals, Vol. 15, Núm. 11
-
N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
Molecules, Vol. 27, Núm. 21
-
Nucleobase-Derived Nitrones: Synthesis and Antioxidant and Neuroprotective Activities in an In Vitro Model of Ischemia–Reperfusion
International Journal of Molecular Sciences, Vol. 23, Núm. 6
-
Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment
Antioxidants, Vol. 11, Núm. 9
-
Postischemic Neuroprotection of Aminoethoxydiphenyl Borate Associates Shortening of Peri-Infarct Depolarizations
International Journal of Molecular Sciences, Vol. 23, Núm. 13
-
Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke
Antioxidants, Vol. 11, Núm. 6
-
Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 37, Núm. 1, pp. 2605-2620
-
Synthesis and Antioxidant Properties of HeteroBisNitrones Derived from Benzene Dicarbaldehydes
Antioxidants, Vol. 11, Núm. 8
-
Synthesis and Pharmacological Evaluation of New N-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout
Journal of Medicinal Chemistry, Vol. 65, Núm. 8, pp. 6250-6260